Recurrent Paraganglioma
1 clinical trials · Condition
◉ Watch Recurrent Paraganglioma
| Record | Firm | Date |
|---|---|---|
| Dovitinib in Neuroendocrine Tumors (NCT01635907) | Abramson Cancer Center at Penn Medicine | 2012-06-01 |
Track Recurrent Paraganglioma automatically
Every clearance here is in the API, with alerts when new ones post.